| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | UNI - EN REPORT No | 73 | / | 2016 | | | |
| | Date of issue: | 2016-08-02 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 73 buy back 02082016 | |
| | Official market - legal basis | | | | | | |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | SOPHARMA AD hereby informs that from 29 July 2016 up to and including 1 August 2016 the Company bought 10 853 own shares representing 0.0081% of the share capital of the Company, at a total value of 29 813.99 BGN on the Bulgarian Stock Exchange, the average price per share was 2.75 BGN.The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 463 774, representing 4.05% of the share capital of the Company.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | | Current report 73 buy back 02082016 | |
